The Federal Government announced that it will fund Chimeric Antigen Receptor T cell (CAR T-cell) therapy with Kymriah for the treatment of acute lymphoblastic leukaemia (ALL) in paediatric and young adult patients who have relapsed or do not respond to initial treatment. This is fabulous news with ALL affecting approximately 30 patients every year. We are still awaiting news on whether the Government will fund the treatment of adult patients...
making hope real for australians
in the fight against blood cancers
-
a focus on new treatments
Right now, cancer research is rapidly growing with the support and introduction of new technology into human genes. Just imagine a treatment that is tailored or personalised to match your type of cancer as well as your personal genetic profile. Well, it’s not a distant dream and it is certainly no research black hole as...
Read More -
2016 Telstra Business Award winner
In August 2016, we were positively thrilled when Telstra announced that we had won the inaugural National Telstra Business Award in the Charity category.
Read More -
blood cancers
Blood cancers are common genetic diseases, but not in the sense that they're conditions you inherit from your parents. Rather, blood cancers are caused by the genes.
Read More -
snowdome’s unique approach
As a strategy-focused organisation, Snowdome is targeting a real need not currently being addressed effectively: To bring next-generation, improved treatments to Australian patients faster.
Read More -
snowdome’s accomplishments
Snowdome is proud to share that 372 Australian blood cancer patients have gained access to new, cutting-edge therapies since Snowdome formed in 2010.
Read More -
snowdome board
Every member of the Snowdome Foundation Board has a strong connection with blood cancer, be it as a doctor or researcher, a survivor, carer, close friend or a relative of someone who is battling, has overcome or has succumbed.
Read More -
chloe’s story
The Snowdome Foundation is dedicated to all who’ve suffered blood cancers, those who’ve survived, those living with and those who have lost the cruellest of battles. Chloe Rutherford was one of those who didn’t make it.
Read More -
related links
The Snowdome Foundation recognised Australian blood cancer patients need significant support & there are wonderful organisations making excellent contributions.
Read More
372
Patients
have gained access to new treatments with Snowdome support
20
Clinical Trials
have commenced with Snowdome infrastructure support
$25
Million
secured and directed to Snowdome prioritized projects
Snowdome in the news
-
-
As of 1st May 2019 Inotuzumab (Besponsa) will be available on the PBS for patients with relapsed acute lymphocytic leukaemia (ALL) or refractory CD22...
-
Chimeric Antigen Receptor T-cell (CAR T-cell) therapies are providing Australian blood cancer patients with real hope. From the Federal Government announcing an investment in...
